22/4/2025, 2:20:04 pm

Laurus Labs bets on cell and gene therapies, eyes CDMO role

Laurus Labs has invested Rs 550 crore in cell and gene therapies via subsidiaries and collaborations, aiming to become a key manufacturing partner. They leverage India's expertise for global markets, building a viral vector facility, and are seeing profitability. They're also adopting advanced technologies like flow chemistry.